Cycloferon is a drug that has been used in the pharmacological practice for over 20 years, since 1992. Its widespread use is due to its effective antiviral and immunomodulating activity and the lack of adverse reactions.

The active ingredient is meglumine acridone acetate, which is effective against not only viruses, but also bacteria and fungi. Meglumine acridone acetate is an inducer of endogenous interferon, which has an antiviral, immunomodulating effect, as well as anti-inflammatory, antiproliferative and antitumor effects.

Due to such properties of the drug, it is supposed to perform the following functions in the human body:

  • Activate bone marrow stem cells;
  • Activate killer cells and T-lymphocytes;
  • Normalize the immune status in HIV-infected people;
  • Exhibit antimicrobial and antichlamydial action;
  • Prevent the development of tumor processes in the body;
  • Suppress autoimmune reactions;
  • Improve the balance of immunity;
  • Inhibit the growth and development of pathogenic viruses, bacteria.

Due to the wide spectrum of action of Cycloferon, it is used not only for the treatment and prevention of acute viral infections, but also in the treatment of other diseases, including oncology.

Cycloferon is included in the List of Essential and Important Medicines in the Russian Federation, as well as in the treatment standards for influenza of varying severity, both in adults and in children. The effect of the drug has been proven and adverse reactions are being monitored in all countries where the drug is registered. Over 200 experimental, clinical and scientific publications have been published on Cycloferon.

Its effectiveness and safety have been confirmed in multicenter randomized clinical, pharmacoeconomic and post-registration studies. The drug does not adversely affect vital organs, in particular the liver, because it is not metabolized in it. It does not accumulate in the body and is excreted by the kidneys in the unchanged form within a day after an administration.

The drug shows good tolerability in children. Numerous randomized clinical studies have shown the epidemiological significance and prevention efficacy of Cycloferon, which is manifested in a decrease of the incidence.